Physiomics Plc (FRA:RVW1)

Germany flag Germany · Delayed Price · Currency is EUR
0.0005
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:00 AM CET
-75.00%
Market Cap 1.01M
Revenue (ttm) 973.13K
Net Income (ttm) -484.44K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0005
Previous Close 0.0005
Day's Range 0.0005 - 0.0005
52-Week Range 0.0005 - 0.0100
Beta n/a
RSI 32.58
Earnings Date Dec 4, 2025

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 10
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RVW1
Full Company Profile

Financial Performance

In 2025, Physiomics's revenue was 834,156, an increase of 46.20% compared to the previous year's 570,561. Losses were -415,254, -31.85% less than in 2024.

Financial numbers in GBP Financial Statements

News

There is no news available yet.